OK
The Universal Selection Source:
Coatings Ingredients
Industry News

LATECBA to Use Hydromer® Hydrophilic Coatings for Endoprostheses Delivery Systems

Published on 2013-07-08. Author : SpecialChem

BRANCHBURG -- Hydromer, Inc. (HYDI.PK) and LATECBA S.A. have entered into a Supply and Support Agreement.

Under the terms of this agreement, LATECBA is licensed to use proprietary Hydromer® hydrophilic coatings for balloon-expandable Endoprostheses delivery systems for an Abdominal Aortic Aneurysm treatment device.

The Hydromer coatings are very lubricious and slippery, reduce friction, improve and ease delivery of LATECBA's catheters through the difficult vascular pathways.

In addition, Hydromer® has unique properties to maintain lubricity and durability while significantly reducing particulates, and remain in compliance with the stringent USP#788 standards.

"We are very excited and pleased that our Hydromer Hydrophilic coating was selected for use on Latecba's innovative balloon-expandable Endoprostheses delivery system for Abdominal Aortic Aneurysms. Hydromer is honored to be building this prestigious relationship with LATECBA," commented Elena McGuire - Product Manager of Hydromer, Inc., adding, "This specific Hydromer coating is been approved for use around the world on Pebax® neurovascular, cardiovascular, peripheral vascular, stent and drug delivery catheters."

About Hydromer, Inc.

Hydromer, Inc. is a bio-technology-based company involved in the research and development, manufacture, contract coating and commercialization of specialized polymer and hydrogel products for medical device, animal health, cosmetic, personal care, and industrial uses. These technologies include Hydromer lubricious / anti-microbial / anti-thrombogenic / cell anti-mitosis / cell growth enhancing coatings for the medical marketplace.

About LATECBA S.A.M

LATECBA S.A is an enterprise which has been developing for the last fourteen years in the area of biomedical products. Its commitment is to satisfy its customers with the highest levels of quality in all products. Founded in 1994, in Buenos Aires, it originally focused on the development and manufacture of the SETA family of endoprostheses to treat vascular diseases.

Source: Hydromer, Inc.


Channel Alerts

Receive weekly digests on hot topics

Back to Top